Blood and Urine Sample Collection From Healthy Volunteers
Study Details
Study Description
Brief Summary
The aim of the study is to obtain blood and urine samples from healthy volunteers to serve as a healthy control group for cross-cohort comparisons.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
The aim of the study is to obtain peripheral venous blood samples and a urine sample from 100 healthy volunteers on one day at three different times of the day, to serve as a healthy control group for cross-cohort comparisons.
With the help of the urine and blood samples obtained in this context, a cohort of a healthy collective is to be established for further research purposes.
Study Design
Outcome Measures
Primary Outcome Measures
- Collection of blood samples from healthy volunteers to serve as a healthy control group. [1 day]
There are no primary endpoints planned; endpoints will be specified in the individual research projects that will utilize the blood samples as a control group.
- Collection of urine samples from healthy volunteers to serve as a healthy control group. [1 day]
There are no primary endpoints planned; endpoints will be specified in the individual research projects that will utilize the urine samples as a control group.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy male and female subjects aged 40-70 years.
-
Caucasian
-
Non-smokers or ex-smokers
-
Body Mass Index (BMI): ≥18.5 and ≤32 kg/m2
-
Presence of a negative SARS-CoV-2 PCR test.
Exclusion Criteria:
-
Complaints that may indicate the presence of an infection, including Covid-19.
-
Pathological alcohol consumption.
-
Positive alcohol breath test at the preliminary examination.
-
Alcohol consumption within the last 24 hours before the start of sampling.
-
History of drug dependence.
-
Positive urine drug test during the preliminary examination.
-
Clinically significant acute or chronic disease. In particular, chronic inflammation, rheumatological and other autoimmune diseases, diabetes and other metabolic diseases.
-
Indications in the medical history or during the medical examination that may jeopardize the safety of the study participant by participating in the study.
-
History of relevant clinically significant cardiovascular disorders or clinically relevant hyper- or hypotension or clinically relevant brady- or tachycardia at screening as assessed by an investigator.
-
Heart rate <45/min after 5 minutes in a quiet sitting position.
-
Heart rate >100/min after 5 minutes in a quiet sitting position.
-
Systolic blood pressure of > 170 mmHg or < 90 mmHg.
-
Diastolic blood pressure of > 95 mmHg and/or < 60 mmHg.
-
Regular use of prescription medication within 3 months prior to inclusion in the research project.
-
Use of non-prescription medications within 3 days prior to inclusion in the research project.
-
Presence of clinically significant food intolerance and/or food allergy as assessed by the investigator.
-
Medically relevant previous operations.
-
Condition following radio- or chemotherapy.
-
History of oncological diseases.
-
Blood and/or plasma donation within the last 30 days prior to sample collection.
-
Pregnant or nursing female.
-
Employees of study site.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CTC North | Hamburg | Germany | 20251 |
Sponsors and Collaborators
- Evotec International GmbH
Investigators
- Study Chair: Hanna Peradziryi, Hanna.Peradziryi@evotec.com
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- EVT_CTC_01